drugset / Trial / NCT01027728
Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid Arthritis
RandomizedSingle-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of multiple oral doses of CCX354-C at a number of dose levels in subjects with stable rheumatoid arthritis (RA).
Timeline
- Start
- 2009-12
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CCX354 | Small molecule | 100 mg | Oral |
| Subject | CCX354 | Small molecule | 200 mg | Oral |